OMCL

Omnicell Inc

36.65

Oct 30 • 3:59 PM ET -0.23 (-0.62%)

36.65

Aftermarket • 7:30 PM ET 0.00 (0.00%)

Healthcare Health Information Services USA Small NASD

Oct 29, 5:48 PMOmnicell beats fiscal Q3 2026 guidance and estimates with EPS $0.58 (+14% YoY), revenue $307.9M (-1% YoY), raises 2026 EBITDA/EPS outlook

Peers: BDX HSTM BAX ICUI WAY SPOK PHR GRDN MCK CAH

| Held by: IJR VTI IWM VB DFSV VBR DFAT VXF IWN SPSM

Scroll to Statements

Index	RUT
Market Cap	1.67B
Enterprise Value	1.52B
Income	44.66M
Sales	1.24B
Book/sh	28.32
Cash/sh	7.40
Dividend Est.	-
Dividend TTM	-
Dividend Ex-Date	-
Dividend Gr. 3/5Y	- -
Payout	0.00%
Employees	3580
IPO	Aug 07, 2001

P/E	38.00
Forward P/E	17.80
PEG	1.44
P/S	1.34
P/B	1.29
P/C	4.95
P/FCF	11.66
EV/EBITDA	9.81
EV/Sales	1.23
Quick Ratio	1.45
Current Ratio	1.66
Debt/Eq	0.14
LT Debt/Eq	0.14
Option/Short	Yes / Yes

EPS (ttm)	0.96
EPS next Y	2.06
EPS next Q	0.41
EPS this Y	50.46%
EPS next Y	-15.54%
EPS next 5Y	12.35%
EPS past 3/5Y	-28.87% -43.00%
Sales past 3/5Y	-2.94% 5.84%
EPS Y/Y TTM	126.76%
Sales Y/Y TTM	5.62%
EPS Q/Q	99.75%
Sales Q/Q	-0.89%
Earnings	Oct 29 BMO
EPS/Sales Surpr.	38.92% 1.12%

Insider Own	3.40%
Insider Trans	-1.35%
Inst Own	107.24%
Inst Trans	4.37%
ROA	2.23%
ROE	3.52%
ROIC	2.96%
Gross Margin	45.14%
Oper. Margin	5.28%
Profit Margin	3.59%
SMA20	1.42%
SMA50	5.91%
SMA200	-6.11%
Trades

Shs Outstand	45.61M
Shs Float	44.06M
Short Float	7.41%
Short Ratio	5.23
Short Interest	3.27M
52W High	51.84 -29.30%
52W Low	30.69 19.42%
Volatility	5.19% 3.77%
ATR (14)	1.41
RSI (14)	55.48
Beta	0.90
Rel Volume	1.26
Avg Volume	624.42K
Volume	785,186

Perf Week	-2.91%
Perf Month	9.60%
Perf Quarter	-2.66%
Perf Half Y	-14.37%
Perf YTD	-19.09%
Perf Year	9.14%
Perf 3Y	3.82%
Perf 5Y	-79.43%
Perf 10Y	12.42%
Recom	1.25
Target Price	58.43
Prev Close	36.88
Price	36.65
Change %	-0.62%

Consensus

Strong Buy

Avg. Price Target

$58.43

Implied Upside

+59.4%

Analysts9incl. previous ratings

Rating Distribution5 Buy · 4 Hold · 0 Sell

Date	Action	Analyst	Rating Change	Price Target Change	Implied Upside
Feb 04, 2026	Upgrade	BBofA Securities	Neutral → Buy	$70	+91.0%
Jan 08, 2026	Upgrade	KKeyBanc Capital Markets	Sector Weight → Overweight	$60	+63.7%
May 14, 2025	Upgrade	WWells Fargo	Equal Weight → Overweight	$35	-4.5%
Oct 31, 2024	Downgrade	BBofA Securities	Buy → Neutral	$44 → $57	+55.5%
Aug 02, 2024	Upgrade	BBarclays	Underweight → Equal Weight	$26 → $39	+6.4%
Jan 03, 2024	Initiated	BBarclays	Underweight	$33	-10.0%
Nov 03, 2023	Upgrade	WWells Fargo	Underweight → Equal Weight	$39 → $28	-23.6%
Nov 03, 2023	Upgrade	PPiper Sandler	Neutral → Overweight	$70 → $39	+6.4%
Nov 03, 2023	Downgrade	BBTIG Research	Buy → Neutral
Oct 11, 2023	Downgrade	KKeyBanc Capital Markets	Overweight → Sector Weight
Sep 26, 2023	Reiterated	WWells Fargo	Underweight	$56 → $39	+6.4%
Aug 02, 2023	Downgrade	PPiper Sandler	Overweight → Neutral	$66 → $70	+91.0%
Jul 20, 2023	Downgrade	WWells Fargo	Overweight → Underweight	$65 → $56	+52.8%
Feb 27, 2023	Upgrade	TThe Benchmark Company	Hold → Buy	$68	+85.5%
Nov 03, 2022	Downgrade	TThe Benchmark Company	Buy → Hold
Sep 16, 2022	Initiated	KKeyBanc Capital Markets	Overweight	$130	+254.7%
Sep 09, 2022	Initiated	BBofA Securities	Buy	$120	+227.4%
Jul 15, 2022	Initiated	SSVB Leerink	Mkt Perform	$124	+238.3%
Dec 06, 2021	Resumed	WWells Fargo	Overweight	$203	+453.9%
Jun 09, 2021	Initiated	JJP Morgan	Neutral	$146	+298.4%

Oct-29-26 11:22AM	Omnicell's Margin-Driven Beat And Third Profit Raise Mask A Top Line Still Waiting On Titan XT (Earnings Whispers)
06:46AM	Omnicell: Q3 Earnings Snapshot (Associated Press)
06:30AM	Omnicell Announces Third Quarter 2026 Financial Results (Business Wire)
Oct-21-26 01:33PM	Omnicell's Bookings Range Faces Its First Test As Earnings Reset After Tariff Windfall (Earnings Whispers)
Oct-08-26 04:01PM	Omnicell to Release Third Quarter 2026 Financial Results on October 29, 2026 (Business Wire)
10:00AM	Loading…
Sep-03-26 10:00AM	TraceLink and Omnicell Integrate DSCSA Compliance Solution into Hospital Pharmacy Operations (PR Newswire)
Aug-31-26 04:01PM	Omnicell to Present at the Wells Fargo 21st Annual Healthcare Conference (Business Wire) +6.29%
Jul-30-26 05:05PM	Omnicell Inc (OMCL) (Q2 2026) Earnings Call Highlights: Strong Profitability and Strategic Wins ... (GuruFocus.com) -10.36%
06:41AM	Omnicell: Q2 Earnings Snapshot (Associated Press)
06:30AM	Omnicell Announces Second Quarter 2026 Financial Results (Business Wire)
Jul-13-26 04:01PM	Omnicell to Release Second Quarter 2026 Financial Results on July 30, 2026 (Business Wire)
Jun-02-26 04:01PM	Omnicell to Present at the Goldman Sachs 47th Annual Global Healthcare Conference 2026 (Business Wire)
May-04-26 04:01PM	Omnicell to Present at the BofA Securities 2026 Healthcare Conference (Business Wire)
Apr-29-26 08:00AM	Omnicell Welcomes Hospital Pharmacy Leader Rick Couldry as Senior Vice President, Chief Pharmacy and Clinical Officer (Business Wire) -5.30%
03:04AM	Omnicell Inc (OMCL) Q1 2026 Earnings Call Highlights: Strong Revenue Growth and Positive ... (GuruFocus.com)
10:37AM	Loading…
Apr-28-26 10:37AM	OMCL Jumps to Profitability With 15% Revenue Growth Raises 2026 Outlook (InvestorsHub) +20.94%
06:44AM	Omnicell: Q1 Earnings Snapshot (Associated Press)
06:30AM	Omnicell Announces First Quarter 2026 Financial Results (Business Wire)
Apr-13-26 05:00PM	Omnicell to Release First Quarter 2026 Financial Results on April 28, 2026 (Business Wire)
Mar-02-26 11:07PM	3 Reasons to Avoid OMCL and 1 Stock to Buy Instead (StockStory)
Feb-28-26 10:07AM	Omnicell, Inc. (OMCL): A Bull Case Theory (Insider Monkey)
Feb-12-26 12:37AM	The Top 5 Analyst Questions From Omnicell's Q4 Earnings Call (StockStory)
Feb-06-26 12:33AM	OMCL Q4 Deep Dive: Product Launches, Tariff Headwinds, and Margin Pressures Shape Outlook (StockStory) -5.14%
Feb-05-26 11:37PM	Omnicell Q4 Earnings Call Highlights (MarketBeat) -16.30%
04:06PM	Omnicell Inc (OMCL) Q4 2025 Earnings Call Highlights: Strong Demand and Strategic Innovations ... (GuruFocus.com)
11:56AM	Why Omnicell (OMCL) Shares Are Plunging Today (StockStory)
07:45AM	Omnicell (OMCL) Q4 Earnings Lag Estimates (Zacks)
06:53AM	Omnicell's (NASDAQ:OMCL) Q4 CY2025 Earnings Results: Revenue In Line With Expectations (StockStory)
06:53AM	Omnicell: Q4 Earnings Snapshot (Associated Press Finance)
06:30AM	Omnicell Announces Fiscal Year and Fourth Quarter 2025 Financial Results (Business Wire)
10:04PM	Loading…
Feb-03-26 10:04PM	Omnicell Earnings: What To Look For From OMCL (StockStory) -5.46%
Feb-01-26 10:31PM	Healthcare Technology for Providers Stocks Q3 Highlights: Omnicell (NASDAQ:OMCL) (StockStory)
Jan-30-26 11:40AM	OMCL or HIMS: Which Is the Better Value Stock Right Now? (Zacks)
Jan-29-26 10:00AM	Earnings Preview: Omnicell (OMCL) Q4 Earnings Expected to Decline (Zacks)
Jan-22-26 03:47AM	Zacks Industry Outlook Highlights Doximity, 10x Genomics and Omnicell (Zacks)
Jan-21-26 09:53AM	3 Medical Info Systems Stocks to Gain From Digitization Despite Industry Woes (Zacks)
07:57AM	Tempus AI's Key 2025 Milestones Continue to Gain Industry Attention (Zacks)
Jan-19-26 11:02PM	3 Reasons to Sell OMCL and 1 Stock to Buy Instead (StockStory)
Jan-16-26 09:34AM	Here's Why You Should Hold DexCom Stock in Your Portfolio for Now (Zacks)
Jan-15-26 12:09PM	CLOV Reports MA Membership Growth, Signals GAAP Profitability in 2026 (Zacks)
09:36AM	Reasons to Add Fresenius Medical Stock to Your Portfolio Now (Zacks)
Jan-13-26 12:00PM	All You Need to Know About Omnicell (OMCL) Rating Upgrade to Buy (Zacks)
11:40AM	OMCL vs. HIMS: Which Stock Is the Better Value Option? (Zacks)
08:01AM	Omnicell to Release Fourth Quarter and Full Year 2025 Financial Results on February 5, 2026 (Business Wire)
Jan-08-26 04:39PM	Stocks Settle Mixed on Sector Rotation (Barchart) +6.62%
01:43PM	Omnicell looks at long-term growth tied to cabinet replacement cycle (Investing.com)
11:23AM	Stock Indexes Mixed on Big Tech Weakness and Higher Bond Yields (Barchart)
Jan-02-26 12:10PM	CapsoVision Submits FDA 510(k) for AI-Assisted Module in CapsoCam Plus (Zacks)
Dec-31-25 10:30AM	KRMD Submits 510(k) to Use FreedomEDGE System With Oncology Biologic (Zacks)
Dec-29-25 09:48AM	Implied Volatility Surging for Omnicell Stock Options (Zacks)
Dec-23-25 12:35PM	FLGT to Acquire Bako & StrataDx Assets to Expand Pathology Platform (Zacks)
Dec-17-25 07:58AM	How the OneStep Partnership Could Drive Growth for ZBH Stock (Zacks)
Dec-16-25 10:00AM	Best Momentum Stocks to Buy for Dec. 16 (Zacks)
05:43AM	New Strong Buy Stocks for Dec. 16: MDB, OMCL, and More (Zacks)
Dec-15-25 09:12AM	CVS Stock Gains From Offering MMR Vaccine to South Carolina Residents (Zacks)
Dec-10-25 08:34AM	Is it Worth Retaining NEOG Stock in Your Portfolio for Now? (Zacks)
08:31AM	Phibro Animal Health Stock Climbs 59.6% YTD: What's Driving It? (Zacks)
Dec-09-25 07:28AM	ALGN Stock Rises on Thailand Launch of Invisalign With MAOB (Zacks)
07:27AM	Reasons to Hold Tandem Diabetes Stock in Your Portfolio for Now (Zacks)
07:26AM	RMD Stock Set to Gain From FDA Clearance of AI-Enabled Smart Comfort (Zacks)
Dec-08-25 11:40AM	OMCL vs. HIMS: Which Stock Should Value Investors Buy Now? (Zacks) +7.54%
08:00AM	Announcing Omnicell Titan XT, the Next Generation, Automated Dispensing System Designed to Empower Autonomous Medication Management (Business Wire)
07:56AM	PODD Stock Benefits From FDA Approval of Omnipod 5's Enhancements (Zacks)
Dec-07-25 11:34PM	1 Healthcare Stock with Impressive Fundamentals and 2 We Brush Off (StockStory)
Dec-05-25 08:48AM	MDT Stock Set to Benefit From the FDA Clearance of Hugo RAS System (Zacks)
08:31AM	Reasons to Add Omnicell Stock to Your Portfolio Right Now (Zacks)
Dec-04-25 11:30AM	Why Is Clover Health Investments (CLOV) Down 11.6% Since Last Earnings Report? (Zacks)
Dec-03-25 11:30AM	Hims & Hers Health (HIMS) Down 15.1% Since Last Earnings Report: Can It Rebound? (Zacks) +5.25%
Nov-27-25 09:55AM	Wall Street Analysts Think Omnicell (OMCL) Could Surge 30.93%: Read This Before Placing a Bet (Zacks)
Nov-20-25 04:01PM	Omnicell to Present at the Piper Sandler 37th Annual Healthcare Conference (Business Wire)
11:40AM	OMCL or HIMS: Which Is the Better Value Stock Right Now? (Zacks)
Nov-10-25 09:55AM	Wall Street Analysts Believe Omnicell (OMCL) Could Rally 34.53%: Here's is How to Trade (Zacks)
Nov-04-25 11:40AM	OMCL vs. HIMS: Which Stock Is the Better Value Option? (Zacks)
09:21AM	Buy 5 Stocks With Extensive Robotics Application for the Rest of 2025 (Zacks)
Nov-03-25 12:20PM	Earnings Estimates Moving Higher for Omnicell (OMCL): Time to Buy? (Zacks)
11:40AM	OMCL vs. HIMS: Which Stock Should Value Investors Buy Now? (Zacks)
Oct-30-25 06:45PM	Why Omnicell Stock Crushed the Market Today (Motley Fool) +13.56%
04:31PM	Omnicell Inc (OMCL) Q3 2025 Earnings Call Highlights: Strong Revenue Growth Amid Market Challenges (GuruFocus.com)
02:35PM	Why Omnicell (OMCL) Stock Is Trading Up Today (StockStory)
07:45AM	Omnicell (OMCL) Q3 Earnings and Revenues Surpass Estimates (Zacks)
06:54AM	Omnicell (NASDAQ:OMCL) Reports Bullish Q3, Stock Soars (StockStory)
06:40AM	Omnicell: Q3 Earnings Snapshot (Associated Press Finance)
06:30AM	Omnicell Announces Third Quarter 2025 Financial Results (Business Wire)
Oct-28-25 11:15PM	Omnicell (OMCL) To Report Earnings Tomorrow: Here Is What To Expect (StockStory)
Oct-27-25 10:00AM	Hims & Hers Health, Inc. (HIMS) Earnings Expected to Grow: What to Know Ahead of Next Week's Release (Zacks)
Oct-24-25 09:55AM	Wall Street Analysts See a 43.74% Upside in Omnicell (OMCL): Can the Stock Really Move This High? (Zacks)
Oct-23-25 10:00AM	Earnings Preview: Omnicell (OMCL) Q3 Earnings Expected to Decline (Zacks)
09:40AM	Are Investors Undervaluing Omnicell (OMCL) Right Now? (Zacks)
Oct-21-25 10:46PM	Omnicell, Inc. (OMCL): A Bull Case Theory (Insider Monkey)
05:19AM	10x Genomics (TXG) Moves 11.1% Higher: Will This Strength Last? (Zacks)
Oct-17-25 11:40AM	OMCL or HIMS: Which Is the Better Value Stock Right Now? (Zacks)
Oct-14-25 03:00PM	NVDA & PLTR Driving AI in Health: Top Health IT Stocks for Q3 Earnings (Zacks)
Oct-07-25 09:40AM	Is Omnicell (OMCL) Stock Undervalued Right Now? (Zacks)
08:23AM	Reasons to Add Omnicell Stock to Your Portfolio Right Now (Zacks)
Oct-06-25 04:01PM	Omnicell to Release Third Quarter 2025 Financial Results on October 30, 2025 (Business Wire)
Oct-02-25 12:43AM	1 Stock Under $50 with Promising Prospects and 2 Facing Challenges (StockStory)
Oct-01-25 11:40AM	OMCL or HIMS: Which Is the Better Value Stock Right Now? (Zacks)
09:30AM	BD & Henry Ford Health Tie-Up to Enhance Community Pharmacy Experience (Zacks)
Sep-30-25 10:05AM	OptimizeRx Bets on AI and Workflow Integration - Will This Pay Off? (Zacks)
Sep-18-25 09:40AM	Is Omnicell (OMCL) a Great Value Stock Right Now? (Zacks)

Show Previous News

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
Njoku Nnamdi	President & COO	Aug 17 '26	Sale	36.85	3,083	113,609	161,224	Aug 18 04:05 PM
Njoku Nnamdi	Officer	Aug 17 '26	Proposed Sale	36.85	3,083	113,609		Aug 17 10:08 AM
LIPPS RANDALL A	CHAIRMAN, CEO	Jul 15 '26	Sale	47.00	10,000	470,000	345,861	Jul 17 04:05 PM
Randall Lipps	Officer	Jul 15 '26	Proposed Sale	47.00	10,000	470,000		Jul 15 04:10 PM
Njoku Nnamdi	EVP, Chief Operating Officer	May 18 '26	Sale	43.22	3,090	133,550	154,785	May 19 05:05 PM
Manley Corey J	EVP&CHIEF LEGAL/ADMIN OFFICER	May 18 '26	Sale	43.22	5,025	217,180	112,783	May 19 05:05 PM
Manley Corey J	Officer	May 18 '26	Proposed Sale	43.22	5,025	217,180		May 18 10:35 AM
Njoku Nnamdi	Officer	May 18 '26	Proposed Sale	43.22	3,090	133,550		May 18 10:26 AM
Manley Corey J	EVP&CHIEF LEGAL/ADMIN OFFICER	Mar 16 '26	Sale	34.69	7,405	256,879	96,717	Mar 17 04:05 PM
Manley Corey J	Officer	Mar 16 '26	Proposed Sale	34.69	7,405	256,879		Mar 16 11:36 AM
Manley Corey J	EVP&CHIEF LEGAL/ADMIN OFFICER	Feb 17 '26	Sale	36.59	4,243	155,251	85,496	Feb 18 04:05 PM
Manley Corey J	Officer	Feb 17 '26	Proposed Sale	36.59	4,243	155,251		Feb 17 10:56 AM
Manley Corey J	EVP&CHIEF LEGAL/ADMIN OFFICER	Jan 08 '26	Sale	49.90	6,106	304,689	91,674	Jan 12 04:05 PM
Manley Corey J	Officer	Jan 08 '26	Proposed Sale	49.90	6,106	304,689		Jan 08 10:30 AM
Manley Corey J	EVP&CHIEF LEGAL/ADMIN OFFICER	Dec 16 '25	Sale	43.30	278	12,037	97,780	Dec 17 04:05 PM
Manley Corey J	Officer	Dec 16 '25	Proposed Sale	43.30	278	12,037		Dec 16 09:48 AM
Manley Corey J	EVP&CHIEF LEGAL/ADMIN OFFICER	Dec 03 '25	Sale	39.90	6,106	243,629	98,282	Dec 05 04:05 PM
Manley Corey J	Officer	Dec 03 '25	Proposed Sale	39.90	6,106	243,629		Dec 03 04:39 PM
LIPPS RANDALL A	CHAIRMAN, PRESIDENT AND CEO	Dec 01 '25	Option Exercise	27.70	28,250	782,525	414,898	Dec 03 04:05 PM
LIPPS RANDALL A	CHAIRMAN, PRESIDENT AND CEO	Dec 01 '25	Sale	35.97	28,250	1,016,093	386,648	Dec 03 04:05 PM
Randall Lipps	Officer	Dec 01 '25	Proposed Sale	35.97	28,250	1,016,092		Dec 01 01:12 PM
Manley Corey J	EVP&CHIEF LEGAL/ADMIN OFFICER	Nov 17 '25	Sale	34.90	3,473	121,208	104,388	Nov 18 04:13 PM
Manley Corey J	Officer	Nov 17 '25	Proposed Sale	34.90	3,473	121,208		Nov 17 10:36 AM

Omnicell, Inc. engages in the provision of medication management automation solutions and adherence tools for healthcare systems and pharmacies. Its solutions include intelligence, platform and interoperability, central pharmacy dispensing, medication adherence, population health and point of care automation. The company was founded by Randall A. Lipps in September 1992 and is headquartered in Fort Worth, TX.

FounderMr. Randall A. Lipps

President & COOMr. Nnamdi N. Njoku

Executive VP & CFOMr. H. Baird Radford III

Executive VPMr. Corey J. Manley J.D.

VPMr. Brian H. Nutt

open in yahoo | open in reuters | open in marketwatch | open in google | open in EDGAR

OMCL

Omnicell Inc

Upgrade your Finviz experience